Correspondence 0001493152-25-001740 from Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc.
Date: Jan. 10, 2025 · CIK: 0001847345 · Accession: 0001493152-25-001740
AI Filing Summary & Sentiment
File numbers found in text: 333-281991
Show Raw Text
CORRESP
1
filename1.htm
188
Grand Street, Unit #195
New
York, NY 10013
January
10, 2025
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Re:
PowerUp
Acquisition Corp.
Registration
Statement on Form S-4
File
No. 333-281991
Ladies
and Gentleman:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned
Registration Statement on Form S-4 be accelerated so that the same will become effective at 4:00 p.m. Eastern Time on January 14, 2025,
or as soon thereafter as practicable.
We
understand that the staff of the Securities and Exchange Commission will consider this request as confirmation by PowerUp Acquisition
Corp. that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered
by the Registration Statement.
Very
truly yours,
POWERUP ACQUISITION CORP.
By:
/s/ Surendra Ajjarapu
Name:
Surendra Ajjarapu
Title:
Chief Executive Officer
cc:
Kate
Bechen, Esq.